Insiders · ALDX

ALDX insider transactions

Aldeyra Therapeutics Inc. (ALDX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ALDX

• 3d
  President and CEO Brady Todd C bought $418,450 worth of shares (250,000 units at $1.67), increasing direct ownership by 17% to 1,721,298 units (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 69d
  SEC Form 4 filed by Brady Todd C

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 80d
  SEC Form 4 filed by Douglas Richard

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 81d
  SEC Form 4 filed by Alfieri Michael

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 297d
  Principal Financial Officer Alfieri Michael bought $13,250 worth of shares (2,500 units at $5.30) (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 298d
  Chief Development Officer Machatha Stephen sold $113,713 worth of shares (22,073 units at $5.15), decreasing direct ownership by 9% to 221,799 units (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 361d
  SEC Form 4 filed by Director Walker Neal

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 361d
  SEC Form 4 filed by Director Miller-Rich Nancy

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 361d
  SEC Form 4 filed by Director Bronstein Ben

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 361d
  SEC Form 4 filed by Director Douglas Richard

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 361d
  SEC Form 4 filed by Director Joyce Martin Joseph

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 361d
  SEC Form 4 filed by Director Phillips Gary M.

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 416d
  SEC Form 4 filed by Director Clark William D

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 416d
  SEC Form 3 filed by new insider Clark William D

  3 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 426d
  Large owner Perceptive Advisors Llc sold $4,828,000 worth of shares (3,400,000 units at $1.42) (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 459d
  SEC Form 4 filed by President and CEO Brady Todd C

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 459d
  SEC Form 4 filed by Chief Development Officer Machatha Stephen

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 594d
  Director Miller-Rich Nancy bought $10,447 worth of shares (922 units at $11.33) (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 636d
  SEC Form 3 filed by new insider Alfieri Michael

  3 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 663d
  Chief Development Officer Machatha Stephen sold $75,975 worth of shares (16,041 units at $4.74), decreasing direct ownership by 6% to 236,771 units (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 663d
  Officer Greenberg Bruce sold $51,313 worth of shares (10,834 units at $4.74), decreasing direct ownership by 8% to 126,382 units (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 732d
  SEC Form 4 filed by Douglas Richard

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 732d
  SEC Form 4 filed by Joyce Martin Joseph

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 732d
  SEC Form 4 filed by Walker Neal

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 732d
  SEC Form 4 filed by Miller-Rich Nancy

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 732d
  SEC Form 4 filed by Bronstein Ben

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 732d
  SEC Form 4 filed by Phillips Gary M.

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 782d
  Machatha Stephen sold $36,503 worth of shares (11,537 units at $3.16), decreasing direct ownership by 4% to 252,812 units (SEC Form 4) (Amendment)

  4/A - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 782d
  Greenberg Bruce sold $44,968 worth of shares (13,201 units at $3.41), decreasing direct ownership by 9% to 130,154 units (SEC Form 4) (Amendment)

  4/A - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 791d
  Perceptive Advisors Llc bought $833,867 worth of shares (177,993 units at $4.68) (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 796d
  Perceptive Advisors Llc bought $1,934,505 worth of shares (504,272 units at $3.84) (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 817d
  Greenberg Bruce sold $44,968 worth of shares (13,201 units at $3.41), decreasing direct ownership by 10% to 120,699 units (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 817d
  Machatha Stephen sold $98,605 worth of shares (29,768 units at $3.31), decreasing direct ownership by 11% to 243,495 units (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 817d
  Brady Todd C sold $580,760 worth of shares (183,238 units at $3.17), decreasing direct ownership by 11% to 1,471,298 units (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 964d
  Perceptive Advisors Llc sold $4,453,308 worth of shares (2,756,499 units at $1.62) (SEC Form 4)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1001d
  SEC Form 4: Brady Todd C exercised 273,058 shares at a strike of $0.55 and covered exercise/tax liability with 73,807 shares, increasing direct ownership by 14% to 1,654,536 units

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1001d
  SEC Form 4: Phillips Gary M. exercised 5,437 shares at a strike of $0.55, increasing direct ownership by 58% to 14,812 units

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1019d
  SEC Form 4: Walker Neal exercised 9,604 shares at a strike of $0.55, increasing direct ownership by 154% to 15,854 units

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1069d
  SEC Form 4 filed by Joyce Martin Joseph

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1069d
  SEC Form 4 filed by Phillips Gary M.

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1069d
  SEC Form 4 filed by Miller-Rich Nancy

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1069d
  SEC Form 4 filed by Bronstein Ben

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1069d
  SEC Form 4 filed by Douglas Richard

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1069d
  SEC Form 4 filed by Walker Neal

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1075d
  SEC Form 4 filed by Bronstein Ben

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1194d
  SEC Form 4 filed by Machatha Stephen

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1194d
  SEC Form 4 filed by Greenberg Bruce

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1194d
  SEC Form 4: Brady Todd C was granted 238,750 shares, increasing direct ownership by 20% to 1,455,285 units

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1397d
  SEC Form 4: Perceptive Advisors Llc bought $867,750 worth of shares (115,000 units at $7.55)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1398d
  SEC Form 4: Perceptive Advisors Llc bought $702,280 worth of shares (97,000 units at $7.24)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1400d
  SEC Form 4: Perceptive Advisors Llc bought $586,767 worth of shares (95,100 units at $6.17)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1403d
  SEC Form 4: Perceptive Advisors Llc bought $584,000 worth of shares (100,000 units at $5.84)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1404d
  SEC Form 4: Perceptive Advisors Llc bought $2,305,350 worth of shares (412,406 units at $5.59)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1405d
  SEC Form 4: Perceptive Advisors Llc bought $728,134 worth of shares (144,185 units at $5.05)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1406d
  SEC Form 4: Perceptive Advisors Llc bought $1,117,279 worth of shares (222,123 units at $5.03)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1407d
  SEC Form 4: Perceptive Advisors Llc bought $596,960 worth of shares (119,392 units at $5.00)

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1420d
  SEC Form 4: Greenberg Bruce was granted 126,087 shares, increasing direct ownership by 1,614% to 133,900 units

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1420d
  SEC Form 4 filed by Brady Todd C

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1420d
  SEC Form 4: Machatha Stephen was granted 185,605 shares, increasing direct ownership by 212% to 273,263 units

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)
• 1442d
  SEC Form 4: Joyce Martin Joseph bought $15,025 worth of shares (4,323 units at $3.48), increasing direct ownership by 22% to 23,967 units

  4 - Aldeyra Therapeutics, Inc. (0001341235) (Issuer)